top of page

FDA Approves First Medical Device for ADHD


FDA Approves First Medical Device for ADHD On April 19, the Food & Drug Administration (FDA) gave the green light to the life sciences company NeuroSigma to market the first medical device designed to treat ADHD.


“This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, PhD, the director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health, said in a statement.


Read more: https://bit.ly/2UTPAat


Source Healthline Media

6 views0 comments

Recent Posts

See All

Medtech industry outlook 2021

Dear all, here are the great sources that caught our eye in the last weeks regarding the medical device industry outlook as of 2021. Including: - EY report, 2021 - McKinsey report, 2021 - MedTech Dive

Comments


bottom of page